In mid-May, Alkor Bio Group of Companies, a developer and manufacturer of laboratory diagnostic reagent kits, announced a significant expansion of the range of oligonucleotides that it is ready to synthesize for third-party organizations. We are talking about the synthesis of simple and modified oligonucleotides, including probes for real-time PCR.

In April 2019, Microbiology laboratory of Alkor bio Group has launched a new product: cytomegalovirus (CMV) antigen (strain AD-169). This antigen can be used as a specific component in the various test systems, intended for the diagnosis CMV infection in the research laboratories and production. CMV antigen is an inactivated component. Today, the laboratory is working on other viral antigens.

In March, Alkor Bio Group of Companies - developer and manufacturer of test systems for laboratory diagnostics using ELISA and PCR - announced the new service: the production of custom monoclonal antibodies. This service can be demanded by pharmaceutical companies, manufacturers of test systems for laboratory diagnostics by the method of immunofermental analysis, researching institutes.

In the middle of December, the Alkor Bio Group of Companies, a developer and manufacturer of test-systems for laboratory diagnostics using ELISA and PCR, received registration certificates from the Russian Federal Health Service for Health Care Surveillance for their new kits: “Intifica Neisseria gonorrhoeae” for real-time PCR detection of gonorrhea and “Intifica Trichomonas vaginalis "to detect Trichomonas DNA by PCR in real time.

In the middle of December, Alkor Bio Group of Companies - developer and manufacturer of test systems for laboratory diagnostics (ELISA and PCR methods) - got a registration certificate from Roszdravnadzor of the Russian Federation for its new kit “Intifica Chlamydia trachomatis ” for real-time PCR detection of Chlamydia trachomatis DNA.